請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/17266完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 許輔 | |
| dc.contributor.author | Yu-Ling Liu | en |
| dc.contributor.author | 劉育靈 | zh_TW |
| dc.date.accessioned | 2021-06-08T00:03:57Z | - |
| dc.date.copyright | 2013-08-20 | |
| dc.date.issued | 2013 | |
| dc.date.submitted | 2013-08-14 | |
| dc.identifier.citation | 水野卓、川合正允（1997）。菇類的化學、生化學。臺北市：國立編譯館。
王伯徹（2008）。台灣商業化栽培食用菇類之特性與利用價值。食品工業，40（5），15-28。 吳文勉（2001）。腸道免疫面面觀。食品工業，33（8），15-20。 柯俊良（1995）。由金針菇分離免疫調節功能蛋白質及分析其胺基酸序列與進行基因選殖和表現。國立台灣大學醫學院生化學研究所博士論文，台北。 胡哲榮（2006）。研究真菌類免疫調節蛋白質之免疫調節活性。中山醫學大學醫學分子毒理學研究所碩士論文，台中。 唐賽文（1993）。真菌類免疫調節蛋白 FIP-fve 作用機制之研究。國立台灣大學醫學院生物化學暨分子生物學研究所碩士論文，台北。 童曼華（2008）。金針菇免疫調節蛋白 FVE 活化小鼠 T 淋巴細胞機制之研究。國立台灣大學園藝學研究所學位論文，台北。 黃惠君（2004）。食藥用菇的營養與藥用價值。食品工業，36（5），25-32。 葉怡真（2006）。金針菇在醫學上的應用。食品工業，38（5），11-24。 Abdel-Aal, E. S. M. (2008). Effects of baking on protein digestibility of organic spelt products determined by two in vitro digestion methods. LWT - Food Science and Technology, 41(7), 1282-1288. Astwood, J. D., Leach, J. N., & Fuchs, R. L. (1996). Stability of food allergens to digestion in vitro. Nature Biotechnology, 14(10), 1269-1273. Chang, H., Chien, P., Tong, M., & Sheu, F. (2007). Mushroom immunomodulatory proteins possess potential thermal/freezing resistance, acid/alkali tolerance and dehydration stability. Food Chemistry, 105(2), 597-605. Chang, H. H., Hsieh, K. Y., Yeh, C. H., Tu, Y. P., & Sheu, F. (2010). Oral administration of an Enoki mushroom protein FVE activates innate and adaptive immunity and induces anti-tumor activity against murine hepatocellular carcinoma. International Immunopharmacology, 10(2), 239-246. Ding, Y., Seow, S. V., Huang, C. H., Liew, L. M., Lim, Y. C., Kuo, I. C., & Chua, K. Y. (2009). Coadministration of the fungal immunomodulatory protein FIP-Fve and a tumour-associated antigen enhanced antitumour immunity. Immunology, 128(1), e881-e894. Esplugues, E., Huber, S., Gagliani, N., Hauser, A. E., Town, T., Wan, Y. Y., O'Connor, W., Jr., Rongvaux, A., Van Rooijen, N., Haberman, A. M., Iwakura, Y., Kuchroo, V. K., Kolls, J. K., Bluestone, J. A., Herold, K. C., & Flavell, R. A. (2011). Control of TH17 cells occurs in the small intestine. Nature, 475(7357), 514-518. Fu, T. T., Abbott, U. R., & Hatzos, C. (2002). Digestibility of food allergens and nonallergenic proteins in simulated gastric fluid and simulated intestinal fluid - A comparative study. Journal of Agricultural and Food Chemistry, 50(24), 7154-7160. Fukushima, M., Ohashi, T., Fujiwara, Y., Sonoyama, K., & Nakano, M. (2001). Cholesterol-lowering effects of maitake (Grifola frondosa) fiber, shiitake (Lentinus edodes) fiber, and enokitake (Flammulina velutipes) fiber in rats. Experimental Biology and Medicine, 226(8), 758-765. Hsieh, C. W., Lan, J. L., Meng, Q., Cheng, Y. W., Huang, H. M., & Tsai, J. J. (2007). Eosinophil apoptosis induced by fungal immunomodulatory peptide-fve via reducing IL-5 alpha receptor. Journal of the Formosan Medical Association, 106(1), 36-43. Hsieh, K. Y., Hsu, C. I., Lin, J. Y., Tsai, C. C., & Lin, R. H. (2003). Oral administration of an edible-mushroom-derived protein inhibits the development of food-allergic reactions in mice. Clinical & Experimental Allergy, 33(11), 1595-1602. Hur, S. J., Lim, B. O., Decker, E. A., & McClements, D. J. (2011). In vitro human digestion models for food applications. Food Chemistry, 125(1), 1-12. Ikekawa, T., Yoshioka, Y., Emori, M., Sano, T., & Fukuoka, F. (1973). Studies on the antitumor activity of polysaccharides from Flammulina velutipes (Curt. ex Fr.) Sing. Cancer chemotherapy reports, 57(1), 85-86. Ko, J. L., Hsu, C. I., Lin, R. H., Kao, C. L., & Lin, J. Y. (1995). A new fungal immunomodulatory protein, FIP-fve isolated from the edible mushroom, Flammulina velutipes and its complete amino acid sequence. European Journal of Biochemistry, 228(2), 244-249. Kunisawa, J., Kurashima, Y., & Kiyono, H. (2012). Gut-associated lymphoid tissues for the development of oral vaccines. Advanced Drug Delivery Reviews, 64(6), 523-530. Lee, Y. T., Lee, S. S., Sun, H. L., Lu, K. H., Ku, M. S., Sheu, J. N., Ko, J. L., & Lue, K. H. (2013). Effect of the fungal immunomodulatory protein FIP-fve on airway inflammation and cytokine production in mouse asthma model. Cytokine, 61(1), 237-244. Martos, G., Contreras, P., Molina, E., & Lope-Fandino, R. (2010). Egg white ovalbumin digestion mimicking physiological conditions. Journal of Agricultural and Food Chemistry, 58(9), 5640-5648. Montilla, N. A., Blas, M. P., Santalla, M. L., & Villa, J. M. M. (2004). Mucosal immune system: A brief review. Inmunologia, 23, 207-216. Moreno, F. J., Mellon, F. A., Wickham, M. S., Bottrill, A. R., & Mills, E. N. (2005). Stability of the major allergen Brazil nut 2S albumin (Ber e 1) to physiologically relevant in vitro gastrointestinal digestion. FEBS Journal, 272(2), 341-352. Ou, C. C., Hsiao, Y. M., Wang, W. H., Ko, J. L., & Lin, M. Y. (2009). Stability of fungal immunomodulatory protein, FIP-gts and FIP-fve, in IFN- production. Food and Agricultural Immunology, 20(4), 319-332. Pereira, E., Barros, L., Martins, A., & Ferreira, I. C. F. R. (2012). Towards chemical and nutritional inventory of Portuguese wild edible mushrooms in different habitats. Food Chemistry, 130(2), 394-403. Saura-Calixto, F., Serrano, J., & Goni, I. (2007). Intake and bioaccessibility of total polyphenols in a whole diet. Food Chemistry, 101(2), 492-501. Schnell, S., & Herman, R. A. (2009). Should digestion assays be used to estimate persistence of potential allergens in tests for safety of novel food proteins? Clinical and Molecular Allergy, 7, 1. Thomas, K., Aalbers, M., Bannon, G. A., Bartels, M., Dearman, R. J., Esdaile, D. J., Fu, T. J., Glatt, C. M., Hadfield, N., Hatzos, C., Hefle, S. L., Heylings, J. R., Goodman, R. E., Henry, B., Herouet, C., Holsapple, M., Ladics, G. S., Landry, T. D., MacIntosh, S. C., Rice, E. A., Privalle, L. S., Steiner, H. Y., Teshima, R., van Ree, R., Woolhiser, M., & Zawodny, J. (2004). A multi-laboratory evaluation of a common in vitro pepsin digestion assay protocol used in assessing the safety of novel proteins. Regulatory Toxicology and Pharmacology, 39(2), 87-98. Untersmayr, E., & Jensen-Jarolim, E. (2006). The effect of gastric digestion on food allergy. Current Opinion in Allergy and Clinical Immunology, 6(3), 214-219. Wang, P. H., Hsu, C. I., Tang, S. C., Huang, Y. L., Lin, J. Y., & Ko, J. L. (2004). Fungal immunomodulatory protein from Flammulina velutipes induces interferon-gamma production through p38 mitogen-activated protein kinase signaling pathway. Journal of Agricultural and Food Chemistry, 52(9), 2721-2725. Wang, X. F., Su, K. Q., Bao, T. W., Cong, W. R., Chen, Y. F., Li, Q. Z., & Zhou, X. W. (2012). Immunomodulatory Effects of Fungal Proteins. Current Topics in Nutraceutical Research, 10(1), 1-11. Wershil, B. K., & Furuta, G. T. (2008). 4. Gastrointestinal mucosal immunity. Journal of Allergy and Clinical Immunology, 121(2 Suppl), S380-383; quiz S415. Wickham, M., Faulks, R., & Mills, C. (2009). In vitro digestion methods for assessing the effect of food structure on allergen breakdown. Molecular Nutrition & Food Research, 53(8), 952-958. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/17266 | - |
| dc.description.abstract | FIP-fve 為純化自金針菇之免疫調節蛋白，研究指出 FIP-fve 可刺激人類周邊血淋巴細胞增生及分泌 IFN-γ，並使免疫反應趨向於 TH1 反應；體內試驗亦發現，口服 FIP-fve 可降低小鼠食物過敏的症狀、延長罹癌小鼠之壽命及抑制腫瘤大小。生物可及性 (bioaccessibility) 是指活性成分自食物基質釋出後，可通過腸胃道的部分，用來評估活性成分的可利用性，其大多採取體外模擬腸胃道消化的試驗來證明。本實驗欲探討金針菇免疫調節蛋白 FIP-fve 經模擬腸胃道消化後之穩定性，並評估其是否具有活化腸道免疫細胞之功能。第一部分，在模擬胃、腸兩階段各別消化中，以含有胃蛋白酶之模擬胃消化液處理，結果顯示 FIP-fve 並不會有所降解，而在含有胰酶之模擬腸道消化液中，FIP-fve 雖少部分被消化並產生兩個片段，但大部分並未被消化。使用模擬連續式腸胃道消化 FIP-fve，其經模擬胃消化兩小時後，再進行模擬腸消化兩小時，透過高效能液相層析儀分析結果顯示 FIP-fve 並無降解。第二部分，實驗發現 FIP-fve 可以刺激腸繫膜淋巴結 (mesenteric lymph node, MLN) 及培耶氏斑 (Peyer’s patches, PP) 細胞產生 IFN-γ，此外，亦發現消化後的 FIP-fve 仍具有調節腸道免疫之活性，可刺激培耶氏斑細胞分泌 IFN-γ，因此推論 FIP-fve 之口服穩定性佳，模擬腸胃道消化並不會使 FIP-fve 降解，可通過消化道到達小腸，具良好之生物可及性。且經消化之 FIP-fve尚有調節腸道免疫之功能，可能進而影響全身性的免疫反應，達到治療疾病的效果。 | zh_TW |
| dc.description.abstract | FIP-fve is an immunomodulatory protein which is purified from Flammulina velutipes. It has been investigated that FIP-fve has the abilities to stimulate the proliferation and the production of cytokine IFN-γ of human peripheral blood mononuclear cells (hPBMC) and skew the T cells toward TH1 immune response. Besides, in vivo studies indicated that the effects of orally administrated FIP-fve in decreasing food-allergic reaction in mice, inhibiting the progression of tumor size and prolonging the life of mice bearing liver cancer. Bioaccessibility stands for the availabilities of bioactive compounds released from food matrix after passing through gastrointestinal tract which is determined by mimicking digestive system in vitro. In this study, we would like to investigate the stability of immunomodulatory protein FIP-fve after passing through gastrointestinal digestion and determine whether its digested product could further activate the cells of gut-associated lymphoid tissue (GALT).
Results showed that during mimicking each stage of digestion in stomach and intestine, FIP-fve was not degraded under the presence of digestive enzyme which contained pepsin. Moreover, after incubated in simulated intestinal fluid (SIF) which contained pancreatin, FIP-fve was slightly digested into fragments but not digested completely. In addition, the mimicked continuous gastrointestinal digestion of FIP-fve was performed for 2 hours. In this case, results determined via HPLC showed that FIP-fve was not degraded during the mimicked gastrointestinal digestion. Furthermore, digested FIP-fve could trigger the activation of mesenteric lymph node (MLN) and Peyer’s patch (PP) cells to generate IFN-γ. Results reveals the effects that the modulation of immune responses on GALT was achieved by stimulating IFN-γ production from Peyer’s patch. Briefly, we could conclude that orally intake of FIP-fve is considerably stable to reach intestine against gastrointestinal digestion. In addition, the potential of immunomodulatory effects of FIP-fve may further affect systemic immune responses and has the possibility to be utilized on therapy studies. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-08T00:03:57Z (GMT). No. of bitstreams: 1 ntu-102-R00628211-1.pdf: 3084026 bytes, checksum: c952fd13d92498d33179b2a81400545a (MD5) Previous issue date: 2013 | en |
| dc.description.tableofcontents | 口試委員會審定書 I
摘要 II ABSTRACT III 目錄 V 表目錄 VII 圖目錄 VIII 第一章 前言 1 第一節 金針菇簡介 1 第二節 生物可及性 (bioaccessibility) 5 第三節 腸道黏膜免疫系統簡介 7 第四節 研究動機與實驗架構 10 第二章 材料與方法 11 第一節 免疫調節蛋白 FIP-fve 之純化 11 第二節 SDS-PAGE 14 第三節 小鼠脾細胞取得 16 第四節 體外模擬胃消化 17 第五節 體外模擬腸道消化 18 第六節 體外模擬胃腸連續消化 19 第七節 以高效液相層析儀 (HPLC) 分析消化後產物 21 第八節 分離腸繫膜淋巴結細胞 22 第九節 分離腸道 Peyer’s patches 細胞 23 第十節 流式細胞儀分析細胞表面分子 25 第十一節 CFSE 標定細胞增生試驗 26 第十二節 酵素連結免疫吸附分析細胞激素 28 第十三節 統計方法 29 第三章 結果 30 第一節 FIP-fve 之純化及其刺激脾細胞之增生並產生 IFN-γ 30 第二節 體外模擬胃腸消化 FIP-fve 31 第三節 體外模擬腸胃道連續消化 FIP-fve 33 第四節 分離 BALB/c 小鼠之 Peyer’s patches 及 MLN並分析其細胞分群 34 第五節 模擬腸胃道消化後之 FIP-fve 刺激 Peyer’s patches 細胞之活性 36 第六節 經模擬腸胃道消化後之 FIP-fve 刺激 MLN 分泌 IFN-γ 37 第四章 討論 39 第一節 FIP-fve 之免疫調節活性 39 第二節 FIP-fve 之消化穩定性 40 第三節 FIP-fve 具藉由調節腸道免疫影響系統性免疫之潛力 41 第四節 結論及未來展望 42 第五章 參考文獻 44 TABLES 50 FIGURES 51 附錄 67 | |
| dc.language.iso | zh-TW | |
| dc.title | 金針菇免疫調節蛋白 FIP-fve 生物可及性之研究 | zh_TW |
| dc.title | Bioaccessibility Study for Fungal Immunomodulatory Protein FIP-fve | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 101-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 周志輝,吳思敬,繆希椿 | |
| dc.subject.keyword | FIP-fve,生物可及性,體外模擬腸胃道消化,腸繫膜淋巴結,培耶氏斑, | zh_TW |
| dc.subject.keyword | FIP-fve,bioaccessibility,in vitro gastrointestinal digestion,mesenteric lymph nodes,Peyer’s patch, | en |
| dc.relation.page | 67 | |
| dc.rights.note | 未授權 | |
| dc.date.accepted | 2013-08-14 | |
| dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
| dc.contributor.author-dept | 園藝暨景觀學系 | zh_TW |
| 顯示於系所單位： | 園藝暨景觀學系 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-102-1.pdf 未授權公開取用 | 3.01 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。